1. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project;C Dye;JAMA: the journal of the American Medical Association,1999
2. Global surveillance for antituberculosis-drug resistance, 1994–1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance;A Pablos-Mendez;The New England journal of medicine,1998
3. Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance;MA Espinal;The New England journal of medicine,2001
4. Clinical characteristics and treatment outcomes of patients with isoniazid-monoresistant tuberculosis;A Cattamanchi;Clinical infectious diseases: an official publication of the Infectious Diseases Society of America,2009
5. Isoniazid-monoresistant tuberculosis in the United States, 1993 to 2003;AJ Hoopes;Arch Intern Med,2008